News / Health

Scientists Develop Mouse With Human Diabetes

Scientists Develop Mouse With Human Diabetes
Scientists Develop Mouse With Human Diabetes

Scientists for the first time have successfully bred mice with a human form of juvenile diabetes. The breakthrough could speed the  development of treatments for the disease, which typically afflicts children and teenagers and can significantly shorten their lives.

Juvenile, or type I, diabetes affects approximately 10 percent of all diabetics. Survival requires strict adherence to a daily regimen of painful insulin hormone injections, and the disease can also cause multiple long-term complications, including blindness, heart disease and kidney failure.

Unlike the adult form of the disease, called Type II diabetes, in which the body stops using insulin properly to convert food sugars into energy, type I diabetes is an autoimmune disorder. The body’s immune system attacks and destroys the beta cells within the pancreas that make insulin.

Until now, scientists trying to develop drugs to calm the immune system of those with juvenile diabetes have had to work with laboratory mice with only a rodent version of the disease - not an ideal situation, say experts, because treatments that might work in mice can be ineffective or harmful in humans.

Matthias G. von Herrath, M.D., Director of the Center for Diabetes Research in California
Matthias G. von Herrath, M.D., Director of the Center for Diabetes Research in California

But Matthias von Herrath, director of the Center for Diabetes Research in California, says having a rodent with human diabetes should speed the development of drugs for type I diabetes.

"You don’t want to put it in humans if you can avoid it, if it’s not a good molecule or not a good drug," he said. "And this mouse allows you to test the real drug, not to make an equivalent that only works in the mouse."

French and British researchers developed the laboratory mouse with human diabetes and they were able to arrest the immune system’s assault on the animal’s beta cells using a human version of an antibody called anti-CD3.

Anti-CD3 is currently undergoing clinical trials as a promising therapy for type I diabetes.  Von Herrath says the antibody does two things:

"They [it] not only take away the cells that are destroying the islets in type I diabetes, at least temporarily, but also they foster what you would call immune regulations - they train your body’s own immune system to regulate better and prevent diseases like type I diabetes," he said.

Von Herrath says the results of the human trials won’t be known for several more months.

A mice model of juvenile diabetes is useful for more than just drug development. Von Herrath says it can help researchers determine proper dosing of medications for diabetics. He says the diabetic mouse could also help researchers identify biological markers indicating when someone is at risk for developing the disease.

An article describing the development of a mouse model with human type I diabetes, and a commentary by Matthias von Herrath, are published this week in the journal Science Translational Medicine.

You May Like

UN: 1 Million Somalis at Risk of Hunger

Group warns region is in dire need of humanitarian aid, with at least 200,000 children under age of five acutely malnourished as drought hits southern, central part of nation More

Human Rights Groups Allege Supression of Freedoms in Thailand

Thailand’s military, police have suppressed release of independent report assessing human rights in kingdom during first 100 days of latest coup More

Jennifer Lawrence Contacts FBI After Nude Photos Hacked

'Silver Linings Playbook' actress' photos were posted on image-sharing forum 4chan; Federal Bureau of Investigations is looking into matter More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Ukraine Schools Resume Classes, Donate to Government Forcesi
X
September 02, 2014 12:58 PM
A new school year has started in Ukraine but thousands of children in the war-torn east are unable to attend because of ongoing clashes with pro-Russia rebels. In Ukraine's capital, patriotic education has become the norm along with donations to support injured security forces fighting to take back rebel-held areas. VOA's Daniel Schearf reports from Kyiv.
Video

Video Ukraine Schools Resume Classes, Donate to Government Forces

A new school year has started in Ukraine but thousands of children in the war-torn east are unable to attend because of ongoing clashes with pro-Russia rebels. In Ukraine's capital, patriotic education has become the norm along with donations to support injured security forces fighting to take back rebel-held areas. VOA's Daniel Schearf reports from Kyiv.
Video

Video US Detainees Want Negotiators for Freedom in North Korea

The three U.S. detainees held in North Korea were permitted to speak with foreign media Monday. The government of Kim Jong Un restricted the topics of the questions, and the interviews in Pyongyang were limited to five minutes. Each of the men asked Washington to send a representative to Pyongyang to secure his release. VOA’s Carolyn Presutti has our story.
Video

Video Internet, Technology Offer New Tools for Journalists

The Internet and rapidly evolving technology is quickly changing how people receive news and how journalists deliver it. There are now more ways to tell a story than ever before. One school in Los Angeles is teaching the next generation of journalists with the help of a state-of-the-art newsroom. Elizabeth Lee has this report.
Video

Video Turkmen From Amerli Describe Survival of IS Siege

Over the past few weeks, hundreds of Shi'ite Turkmen have fled the town of Amerli seeking refuge in the northern city of Kirkuk. Despite recent military gains after U.S. airstrikes that were coordinated with Iraqi and Kurdish forces, the situation remains dire for Amerli’s residents. Sebastian Meyer went to Kirkuk for VOA to speak to those who managed to escape.
Video

Video West Africa Ebola Vaccine Trials Possible by Early 2015

A U.S. health agency is speeding up clinical trials of a possible vaccine against the deadly Ebola virus that so far has killed more than 1,500 people in West Africa. If successful, the next step would be a larger trial in countries where the outbreak is occurring. VOA's Carol Pearson has more.
Video

Video Survivors Commemorate 70th Anniversary of Nazi Liquidation of Jewish Ghetto

When the German Nazi army occupied the Polish city of Lodz in 1939, it marked the beginning of a long nightmare for the Jewish community that once made up one third of the population. Roughly 200,000 people were forced into the Lodz Ghetto. Less than 7,000 survived. As VOA’s Kane Farabaugh reports, some survivors gathered at the Union League Club in Chicago on the 70th anniversary of the liquidation of the Lodz Ghetto to remember those who suffered at the hands of the Nazi regime.
Video

Video Cost to Raise Child in US Continues to Rise

The cost of raising a child in the United States continues to rise. In its latest annual report, the U.S. Department of Agriculture says middle income families with a child born in 2013 can expect to spend more than $240,000 before that child turns 18. And sending that child to college more than doubles that amount. VOA’s Deborah Block visited with a couple with one child in Alexandria, Virginia, to learn if the report reflects their lifestyle.
Video

Video Chaotic Afghan Vote Recount Threatens Nation’s Future

Afghanistan’s troubled presidential election continues to be rocked by turmoil as an audit of the ballots drags on. The U.N. says the recount will not be completed before September 10. Observers say repeated disputes and delays are threatening the orderly transfer of power and could have dangerous consequences. VOA correspondent Meredith Buel reports.

AppleAndroid